We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+16.95%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$1.52B
AUM Growth
-$7.28B
Cap. Flow
-$6.76B
Cap. Flow %
-444.29%
Top 10 Hldgs %
100%
Holding
929
New
–
Increased
6
Reduced
3
Closed
920

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$184M
2
FHN icon
First Horizon
FHN
+$107M
3
SGFY
Signify Health, Inc.
SGFY
+$54.9M
4
VMW
VMware, Inc
VMW
+$34.9M
5
ONEM
1Life Healthcare
ONEM
+$29.7M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$572M
2
ZEN
ZENDESK INC
ZEN
+$456M
3
ROG icon
Rogers Corp
ROG
+$432M
4
AVLR
Avalara, Inc.
AVLR
+$373M
5
SWCH
Switch, Inc. Class A Common Stock
SWCH
+$271M

Sector Composition

Rank Sector Weight
1 Technology 45.54%
2 Healthcare 36.97%
3 Financials 14.43%
4 Communication Services 3.06%
5 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OHI icon
226
Omega Healthcare
OHI
$14.8B
– –
-57,145
Closed -$1.69M
OMF icon
227
PUT
OneMain Financial
OMF
$7.48B
– –
-27,900
Closed -$235K
ON icon
228
ON Semiconductor
ON
$18.6B
– –
-32,770
Closed -$2.04M
OPTX icon
229
Syntec Optics
OPTX
$298M
– –
-190,898
Closed -$1.92M
OPTXW icon
230
Syntec Optics Holdings Warrant
OPTXW
$16.1M
– –
-49,491
Closed -$6K
ORIC icon
231
Oric Pharmaceuticals
ORIC
$1.34B
– –
-343,002
Closed -$1.1M
OVV icon
232
Ovintiv
OVV
$16.6B
– –
-99,613
Closed -$4.58M
OXY icon
233
Occidental Petroleum
OXY
$56B
– –
-56,512
Closed -$3.47M
OXY icon
234
PUT
Occidental Petroleum
OXY
$56B
– –
-77,100
Closed -$16K
OXY.WS icon
235
Occidental Petroleum Corp Warrants
OXY.WS
$32.2B
– –
-1,158,948
Closed -$45.9M
PATH icon
236
UiPath
PATH
$7.25B
– –
-125,000
Closed -$1.58M
PBF icon
237
PBF Energy
PBF
$7.26B
– –
-71,058
Closed -$2.5M
PDD icon
238
Pinduoduo
PDD
$129B
– –
-20,662
Closed -$1.29M
PDM
239
Piedmont Realty Trust
PDM
$1.18B
– –
-43,290
Closed -$457K
PEN icon
240
Penumbra
PEN
$12.8B
– –
-8,907
Closed -$1.69M
PFSI icon
241
PennyMac Financial
PFSI
$4B
– –
-79,118
Closed -$3.39M
PHAT icon
242
Phathom Pharmaceuticals
PHAT
$679M
– –
-154,093
Closed -$1.71M
PLD icon
243
Prologis
PLD
$132B
– –
-58,463
Closed -$5.94M
PLTR icon
244
Palantir
PLTR
$375B
– –
-225,000
Closed -$1.83M
PLUG icon
245
Plug Power
PLUG
$2.89B
– –
-547,196
Closed -$11.5M
PRAX icon
246
Praxis Precision Medicines
PRAX
$10.3B
– –
-7,718
Closed -$263K
PSA icon
247
Public Storage
PSA
$61.1B
– –
-51,314
Closed -$15M
PSQH icon
248
PSQ Holdings
PSQH
$14.3M
– –
-31,816
Closed -$4.66M
PTGX icon
249
Protagonist Therapeutics
PTGX
$9.46B
– –
-232,820
Closed -$1.96M
PWR icon
250
Quanta Services
PWR
$100B
– –
-133,478
Closed -$17M
8 9
10
11 12

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 929 positions worth $1.52B, down 83% from $8.8B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

UBS O'Connor withdrew a net $6.76B in Q4 2022, closing 920 positions and reducing 3 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

Against the trend, UBS O'Connor added an estimated $184M to Horizon Therapeutics Public Limited Company Ordinary Shares.

  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Activision Blizzard, cutting an estimated $45.3M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 100% of its $1.52B portfolio in Q4 2022.
  • UBS O'Connor opened 0 new positions and closed 920 in Q4 2022.
  • UBS O'Connor's portfolio value fell 83% quarter-over-quarter to $1.52B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.